Volunteer Opportunities

HOPA is looking for well-qualified individuals with expertise in biosimilar drugs. The intent of this call for volunteers is to create a list of individuals with expertise in this area. As items related to this topic are brought up, HOPA expects to be able to quickly identify individuals able to formulate a response or path forward. Some of these items may be regulatory and legislative in nature while others may be scientific and practice related.


  • HOPA member in good standing
  • 5+ years of expertise and knowledge related to biosimilars
  • General knowledge about HOPA’s strategic plan and priorities
  • Ability to attend calls and meetings
  • Ability to meet deadlines

Note: Volunteers will be contacted when HOPA receives specific requests.

HOPA is looking for contributors to the newsletter.


  • HOPA member in good standing

Note: Volunteers will be contacted when HOPA receives specific requests.

The HOPA Research Grant Reviewers Committee is seeking volunteer grant reviewers to assist with reviewing full grant proposals for this year's HOPA Research Grant. If selected you will be asked to review at least one grant in a topic area of your expertise.

Eligibility to serve: HOPA members with experience in peer reviewing grants.

Interested applicants are asked to submit their interest in the VAC as well as complete a short survey. Click HERE to access the survey.

Brief project background: USP has released a proposed rule for General Chapter <797> Pharmaceutical Compounding - Sterile Preparations. HOPA is looking for up to 5 members with safe handling and clean room management experience or responsibility to advise HOPA on the impact of these changes.

Member Experience/Background Needed: Extensive experience (10-20 years) with Safe Handling and clean room management or responsibility

Timeframe of Project: Must review proposed changes, participate in several conference calls and help to write comments, project ends at the end of November

Output/Work Product Expectations: Review USP <797> proposed rule and advise HOPA of impact to pharmacists (and ultimately patients), write comments on the proposed rules to be submitted to USP